Actualités 2024/04/17 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 2024/04/17 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 2024/03/20 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
News 2024/02/14 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
News 2023/10/19 Mimix Biotherapeutics’ breakthrough tissue regeneration treatment receives strategic investment Biel-based Mimix Biotherapeutics announced the closure of a significant investment round, drawing participation from both European and Asian inve...
News 2024/02/06 QUMEA secures investment of 9 million Swiss francs QUMEA has raised funding of 9 million Swiss francs as part of an oversubscribed Series A financing round. With this fresh capital, the digital he...
News 2024/02/08 Canton of St.Gallen seeks to further bolster its start-up scene The government of the canton of St.Gallen is striving to more actively promote start-ups and entrepreneurial ambitions. To this end, the governme...
News 2024/01/11 ETH sets annual record for spin-offs In 2023, more start-ups were founded at the Swiss Federal Institute of Technology in Zurich (ETH) than ever before. Of the 43 spin-offs, 12 have ...
Actualités 2023/11/03 Un nouveau gel offre un soulagement ciblé aux patients atteints de colite ulcéreuse Des chercheurs de l’Université de Berne ont mis au point un gel lipidique pour le traitement direct et localisé de la colite ulcéreuse, dans le b...
Expertise 2022/12/12 EEN: a support network for SMEs seeking partnerships throughout Europe and beyond With negotiations on the future of Swiss-EU relations at a standstill, Swiss SMEs need – now more than ever – to find partnerships to help grow t...
News 2024/01/22 DISCO Pharmaceuticals secures seed funding of 20 million euros DISCO Pharmaceuticals has secured seed funding of 20 million euros and officially launched the business. The team was the first to develop a meth...
News 2024/01/10 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
Aktuell 2023/09/08 Growth Advisory der UBS fördert die Bau-Software von smino Die smino AG bekommt von Growth Advisory, dem Start-up-Förderer der UBS, eine Wachstumsfinanzierung. Damit kann der Anbieter einer Software für P...
News 2023/12/22 Zynnon hits milestone in the diagnosis of respiratory infections Zynnon has reached a milestone with its technology for diagnosing viral respiratory infections. Following successful studies in hospitals, the co...
Actualités 2023/09/05 Neurosoft innove avec sa technologie pionnière d’interface cérébrale Basée au Campus Biotech à Genève, Neurosoft Bioelectronics a réalisé avec succès un essai clinique révolutionnaire de sa grille d'électrodes exte...